Greeley Tribune on MSN6h
Banner Health: RSV vaccine significantly lowers risk of newborns contracting respiratory illness
Banner Health encourages pregnant women to reduce their newborn’s risk of developing a severe illness through vaccination. Respiratory syncytial virus (RSV) season typically peaks in the winter and ...
The American Journal of Managed Care14h
Subcutaneous Ocrelizumab Well Tolerated in Patients With MS
Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing and primary progressive multiple sclerosis ...
interaksyon.philstar14h
hMPV may be spreading in China. Here’s what to know about this virus – and why it’s not cause for alarm
Five years on from the first news of COVID, recent reports of an obscure respiratory virus in China may understandably raise ...
Kidney disease compromises survival of infection-fighting cells, study reveals
Fighting off infections when one has a chronic disease is a common problem, and during the COVID-19 pandemic that scenario ...
Dx&Vx, From mRNA Vaccines to Nanoparticle Vaccines era of Next-Generation Vaccines
The COVID-19 pandemic has fundamentally transformed global healthcare systems and vaccine technologies. The accelerated approval and rapid distribution of mRNA vaccines introduced a new paradigm in ...
Chugai and Araris enter $780m ADC research collaboration
Araris will use its linker technology to generate multi-warhead ADCs for “undisclosed targets” provided by Chugai.
Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals
Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), comments on the many viruses that could cause pandemics that are going around already.